Evidence map›Paper›PMID 34642602›Full record

ArticleAnnals of medicine and surgery (2012)2021

Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: Cases series.

Ikram Zaid, Ounci Essaad, Ghizlane El Aidouni, Mohammed Aabdi, Samia Berrichi, Salma Taouihar, Manal Marbouh, Houssam Bkiyer, Naima Abda, Brahim Housni

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ikram ZaidDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Ounci EssaadDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Ghizlane El AidouniDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Mohammed AabdiDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Samia BerrichiDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Salma TaouiharDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Manal MarbouhDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Houssam BkiyerDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Naima AbdaFaculty of Medicine and Pharmacy, Mohammed 1st University, Oujda, Morocco.
Brahim HousniDepartment of Intensive Care Unit, Mohammed VI University Hospital, Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID 19 pneumonia can lead to an inappropriate inflammatory response, and can be complicated by acute respiratory distress syndrome, multivisceral failure with a high mortality rate.

objectiveTo observe the effect of therapeutic plasma exchange on the excessive inflammatory response. MATERIALS AND

methodsIn this study, we included 7 confirmed cases of COVID-19 in the intensive care unit (ICU) department of the university hospital of Oujda. COVID-19 cases were confirmed by RT PCR (reverse transcription-polymerase chain) and CT (computerized tomography) imaging according to WHO guidelines. Therapeutic plasma exchange was performed decrease cytokine storm-induced ARDS (Acute respiratory distress syndrome). Inflammation marker assays were performed before and after therapeutic plasma exchange to assess its efficacy.

resultsLevels of inflammatory cytokines (IL-6) and acute phase response proteins, including ferritin and CRP, were elevated before therapeutic plasma exchange.After therapeutic plasma exchange, levels of acute phase reactants, inflammatory mediators, were significantly reduced (p < 0.05).

conclusionOur data suggest that therapeutic plasma exchange reduces the inflammatory response in patients with severe COVID-19 not undergoing mechanical ventilation. Further studies are needed to explore the efficacy of therapeutic plasma exchange in patients with COVID-19.

Indexed as

Acute respiratory distress syndromeCOVID 19 pneumoniaCytokine stromTherapeutic plasma exchange

Identifiers

PMID34642602
PMCPMC8495054
OpenAlexW3207000052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.